Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] SK hynix(000660) – Report on Reason for Holding Shareholders’ Meeting on Concentrated Date / 2024-03-06

Posted on March 6, 2024July 29, 2026 By K-STOCK Editor No Comments on [Disclosure] SK hynix(000660) – Report on Reason for Holding Shareholders’ Meeting on Concentrated Date / 2024-03-06

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

SK hynix submitted a report explaining its decision to hold its 76th Annual General Meeting on March 27, 2024—a designated concentrated date—along with details on its electronic voting system.

📊 [Key Disclosure Details & Financial Summary]

  • General Shareholders’ Meeting Overview
    • Company Name: SK hynix Inc.
    • Scheduled Meeting Date: March 27, 2024
    • Convocation Notice/Announcement Date: March 06, 2024
  • Reason for Holding Meeting on Concentrated Date & Voting Access
    • Reason: Unavoidable alignment due to group affiliate schedules and board member availability
    • Voting Rights Support: Implementation of an electronic voting system, allowing shareholders to exercise voting rights without attending in person
  • Other Key Notes
    • Non-participation in the ‘Voluntary AGM Date Dispersion Program’ hosted by the Korea Listed Companies Association
    • Designated Concentrated Meeting Dates for the Year: March 22, 2024 (Fri), March 27, 2024 (Wed), March 29, 2024 (Fri)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Monitoring Voting Rights Execution and Voting Results at the AGM

This disclosure reports the operational background and electronic voting measures provided to facilitate shareholder voting as the AGM falls on a concentrated meeting date. Checking shareholder participation via electronic voting and verifying final voting outcomes is important for understanding governance transparency and the approval status of proposed resolutions. Final voting outcomes can be verified in the official ‘Results of General Shareholders’ Meeting’ disclosure published after the meeting.

📢 Disclaimer & Fact Source

Source: This content was newly generated and structured based on official disclosure data from the Financial Supervisory Service’s DART system.

Investment Risk Warning: This content is provided solely for information purposes and linguistic reference. Under no circumstances does it constitute financial advice or a recommendation to buy/sell specific stocks. All investment decisions and financial responsibilities lie entirely with the investor.

Contact Us: For compliance queries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Samsung Biologics (207940) – (Correction) Sales / Supply Contract / 2024-03-06
Next Post: [Disclosure] SK hynix(000660) – Decision on Calling of General Shareholders’ Meeting / 2024-03-06

Related Posts

[Disclosure] ISU PETASYS (007660) – Decision on Cash and In-Kind Dividend / 2024-02-20 Semiconductors
[Disclosure] SK square (402340) – Report on Reason for Holding General Shareholders Meeting on Concentrated Dates / 2026-02-24 Semiconductors
[Disclosure] Jusung Engineering (036930) – Change in Sales or Profit/Loss Structure by More Than 30% (15% for Large Companies) / 2026-02-10 Semiconductors
[Disclosure] SK hynix (000660) – Decision on Rights Offering (Correction Disclosure) / 2026-03-03 Semiconductors
[Disclosure] SK Square (402340) – Decision on Record Date for Cash/In-Kind Dividend / 2025-07-23 Semiconductors
[Disclosure] Hanmi Semiconductor (042700) – Corporate Value-up Plan (Voluntary Disclosure) / 2025-04-11 Semiconductors

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme